CORZ vs SNX
Core Scientific, Inc. vs TD Synnex — AI-powered side-by-side comparison
CORZ
Core Scientific, Inc.
60
Buy
VS
| Metric | CORZ | SNX |
|---|
| AI Score |
60
|
70
|
| Price |
$19.76
|
$253.78
|
| P/E Ratio |
-4.66×
|
18.04×
|
| ROE |
30.0%
|
9.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
28.3%
|
6.8%
|
| Debt / Equity |
-1.78×
|
0.53×
|
| Dividend Yield |
0.0%
|
0.7%
|
| RSI (14) |
38.6
|
49.5
|
| Beta |
5.592
|
1.436
|
| Expected Upside |
—
|
+16.8%
|
AI Committee View
Current Innellis committee reasoning for CORZ versus SNX.
SNX leads by 10 points.
SNX scores 70/100 (Buy) versus CORZ at 60/100 (Buy).
CORZ Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 26.4% yoy -- genuine top-line momentum. Risk Analyst remains cautious — bollinger bandwidth of 28.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price-to-book of 0.3x is a discount to asset value — Value
- Revenue growing 26.4% YoY -- genuine top-line momentum — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- ROE of only -94.1% -- cheap may mean cheap for a reason — Value
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 28.5% signals elevated volatility — Risk
SNX Committee View
100% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Price-to-book of 1.5x is a discount to asset value — Value
- EPS growing 63.4% YoY — Growth
- 3 consecutive earnings beats -- consistent execution — Growth
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth